MedPath

Greenstone LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

65

FDA:65

Drug Approvals

medroxyprogesterone acetate

Approval Date
Mar 22, 2024
FDA

Methylprednisolone

Approval Date
Jan 25, 2024
FDA

Hydrocortisone

Approval Date
Jan 23, 2024
FDA

MESALAMINE

Approval Date
Dec 30, 2023
FDA

Mesalamine

Approval Date
Dec 19, 2023
FDA

Sirolimus

Approval Date
Nov 21, 2023
FDA

clindamycin palmitate hydrochloride

Approval Date
Nov 17, 2023
FDA

Sirolimus

Approval Date
Nov 1, 2023
FDA

Risedronate Sodium

Approval Date
Oct 25, 2023
FDA

Risedronate Sodium

Approval Date
Oct 1, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.